Annual Long Term Debt
$104.34 M
-$89.72 M-46.23%
December 31, 2022
Summary
- As of March 4, 2025, SRNE annual long term debt is $104.34 million, with the most recent change of -$89.72 million (-46.23%) on December 31, 2022.
- During the last 3 years, SRNE annual long term debt has fallen by -$146.86 million (-58.46%).
- SRNE annual long term debt is now -58.46% below its all-time high of $251.20 million, reached on December 31, 2019.
Performance
SRNE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$74.19 M
-$31.68 M-29.92%
June 30, 2023
Summary
- As of March 4, 2025, SRNE quarterly long term debt is $74.19 million, with the most recent change of -$31.68 million (-29.92%) on June 30, 2023.
- Over the past year, SRNE quarterly long term debt has dropped by -$31.68 million (-29.92%).
- SRNE quarterly long term debt is now -74.22% below its all-time high of $287.75 million, reached on September 30, 2019.
Performance
SRNE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
SRNE Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.2% | -29.9% |
| 3 y3 years | -58.5% | -29.9% |
| 5 y5 years | +1902.3% | -29.9% |
SRNE Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.2% | at low | -61.8% | at low |
| 5 y | 5-year | -58.5% | at low | -70.5% | at low |
| alltime | all time | -58.5% | +2274.6% | -74.2% | >+9999.0% |
Sorrento Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $74.19 M(-29.9%) |
| Mar 2023 | - | $105.86 M(+1.5%) |
| Dec 2022 | $104.34 M(-46.2%) | $104.34 M(+2.4%) |
| Sep 2022 | - | $101.93 M(-39.1%) |
| Jun 2022 | - | $167.38 M(-6.7%) |
| Mar 2022 | - | $179.49 M(-7.5%) |
| Dec 2021 | $194.06 M(+36.1%) | $194.06 M(+18.7%) |
| Sep 2021 | - | $163.43 M(+24.8%) |
| Jun 2021 | - | $130.96 M(+1.3%) |
| Mar 2021 | - | $129.31 M(-9.3%) |
| Dec 2020 | $142.56 M(-43.2%) | $142.56 M(-29.0%) |
| Sep 2020 | - | $200.69 M(+1.2%) |
| Jun 2020 | - | $198.23 M(-15.7%) |
| Mar 2020 | - | $235.05 M(-6.4%) |
| Dec 2019 | $251.20 M(+12.6%) | $251.20 M(-12.7%) |
| Sep 2019 | - | $287.75 M(+4.4%) |
| Jun 2019 | - | $275.63 M(-0.6%) |
| Mar 2019 | - | $277.29 M(+24.3%) |
| Dec 2018 | $223.14 M | $223.14 M(+53.3%) |
| Sep 2018 | - | $145.53 M(+798.2%) |
| Jun 2018 | - | $16.20 M(+194.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $5.50 M(+5.6%) |
| Dec 2017 | $5.21 M(-88.9%) | $5.21 M(-78.8%) |
| Sep 2017 | - | $24.57 M(-7.4%) |
| Jun 2017 | - | $26.54 M(+1.8%) |
| Mar 2017 | - | $26.08 M(-44.6%) |
| Dec 2016 | $47.11 M(+972.1%) | $47.11 M(>+9900.0%) |
| Sep 2016 | - | $458.00 K(-74.6%) |
| Jun 2016 | - | $1.80 M(-42.1%) |
| Mar 2016 | - | $3.11 M(-29.2%) |
| Dec 2015 | $4.39 M(-50.2%) | $4.39 M(-22.2%) |
| Sep 2015 | - | $5.65 M(-17.8%) |
| Jun 2015 | - | $6.87 M(-10.3%) |
| Mar 2015 | - | $7.66 M(-13.3%) |
| Dec 2014 | $8.83 M(+99.3%) | $8.83 M(+4.5%) |
| Sep 2014 | - | $8.45 M(-10.5%) |
| Jun 2014 | - | $9.44 M(-8.5%) |
| Mar 2014 | - | $10.32 M(+132.8%) |
| Dec 2013 | $4.43 M | $4.43 M(-7.4%) |
| Sep 2013 | - | $4.79 M(+793.9%) |
| Jun 2013 | - | $535.30 K(-12.0%) |
| Mar 2013 | - | $608.30 K |
FAQ
- What is Sorrento Therapeutics annual long term debt?
- What is the all time high annual long term debt for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual long term debt year-on-year change?
- What is Sorrento Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly long term debt year-on-year change?
What is Sorrento Therapeutics annual long term debt?
The current annual long term debt of SRNE is $104.34 M
What is the all time high annual long term debt for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual long term debt is $251.20 M
What is Sorrento Therapeutics annual long term debt year-on-year change?
Over the past year, SRNE annual long term debt has changed by -$89.72 M (-46.23%)
What is Sorrento Therapeutics quarterly long term debt?
The current quarterly long term debt of SRNE is $74.19 M
What is the all time high quarterly long term debt for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly long term debt is $287.75 M
What is Sorrento Therapeutics quarterly long term debt year-on-year change?
Over the past year, SRNE quarterly long term debt has changed by -$31.68 M (-29.92%)